The course will run from 3-5 November 2016.
To view the course flyer, please click here.
THURSDAY 3 NOVEMBER
| 08:00 | Opening Remarks | V Falk, Berlin |
| Part I: Sweet Freedom – Heart Failure Network Chairs: P Mohasci, Bern; F Schönrath, Berlin |
||
| 08:05 | Medical therapy: What’s new in 2016? | E Braunwald, Boston |
| 08:35 | Inflammatory heart disease: What we can and cannot treat | C Tschöpe, Berlin |
| 08:50 | Treating coronary artery disease in heart failure: When is it too late? | U Landmesser, Berlin |
| 09:05 | Structural valve disease in heart failure: Treating the cause or the symptom? | H Ince, Berlin |
| 09:20 | What to expect from a regional Heart Failure Network | B Pieske, Berlin |
| 09:35 | Panel discussion | |
| 10:00 | Break | |
| Part II: Be Quick or Be Dead – Short-term support in acute heart failure Chairs: M Morshuis, Bad Oeynhausen; F Pappalardo, Milan |
||
| 10:30 | Live-in-a-box Case I: Percutaneous extracorporeal membrane oxygenation insertion: How to do it | A El-Banayosy, Oklahoma City |
| 10:50 | Extra corporeal life support in cardiogenic shock: A life saver! | U Böcken, Dusseldorf |
| 11:10 | Partial support: Too much to die, too little to live? | L Bruch, Berlin |
| 11:30 | Predictors for survival on extra corporeal life support |
F Pappalardo, Milan |
| 11:50 | Is it time for an INTERMACS level I re-classification? | P Leprince, Paris |
| 12:10 | Assessing organ recovery during extra corporeal life support: Timing is everything! | F Hennig, Berlin |
| 12:30 | Panel Discussion | |
| 12:40 | Lunch | |
| Part III: Magic Mirror – Are we appropriately utilizing VAD therapy? Chairs: E Braunwald, Boston; J Gummert, Bad Oeynhausen |
||
| 13:30 | Epidemiological considerations | F Schönrath, Berlin |
| 13:50 | According to: The 2016 ESC Guidelines for Heart Failure | C Schulze, Jena |
| 14:10 | According to: The 2013 AHA/ACCF/ACC Heart Failure Guidelines | J Fang, Salt Lake City |
| 14:30 | According to: The 2013 ISHLT Guidelines for Mechanical Circulatory Support | S Pamboukian, Birmingham, AL |
| 14:50 | Panel Discussion | |
| 15:00 | Rising Force: EUROMACS report | T DeBy, Berlin |
| 15:15 | Break | |
| Part IV: If You (Don’t) Want Blood – Minimally invasive ventricular assist device surgery Chairs: J Garbade, Leipzig; D Zimpfer, Vienna |
||
| 15:45 | Strategies for and benefits of non-sternotomy and off-pump approaches | T Krabatsch, Berlin |
| 16:00 | Live-in-a-box Case II: VAD: Partial sternotomy | J Schmitto, Hannover |
| 16:15 | Live-in-a-box Case III: VAD: Partial sternotomy | I Netuka, Prague |
| 16:30 | Live-in-a-box Case IV: Bilateral thoracotomy | E Potapov, Berlin |
| 16:45 | Panel Discussion | |
| Part V: The Cure – Ventricular assist device weaning Chairs: M Morshuis, Bad Oeynhausen; S Tsui, Cambridge |
||
| 17:00 | The optimal weaning protocol | J Fang, Salt Lake City |
| 17:15 | Impact of pump settings | M Slaughter, Louisville |
| 17:30 | The value of adjunctive stem cell therapy | C Patel, North Carolina |
| 17:45 | State of the art and perspectives | JE Rame, Philadelphia |
| 18:00 | Close |
FRIDAY 4 NOVEMBER
| Part I: Sad but True – Right ventricular failure and left ventricular assist device Chairs: T Krabatsch, Berlin; C Opitz, Berlin |
||
| 08:00 | Right and left ventricle: Enemy, friends or couple? | A Redington, Toronto |
| 08:15 | A left ventricular assist device is always enough | W Dembitsky, San Diego |
| 08:30 | Right ventricular support is sometimes needed | G Gerosa, Padua |
| 08:45 | Prospective study to improve postoperative right ventricular function | JE Rame, Philadelphia |
| 09:00 | Total artificial heart for all | F Arabia, Los Angeles |
| 09:15 | Panel discussion | |
| 09:30 | Break | |
| Part II: The Song Remains the Same – How to reduce side effects of long-term left ventricular assist device therapy Chairs: J Long, Oklahoma City; E Potapov, Berlin |
||
| 10:00 | Surgical site infection – prevention and treatment | E Potapov, Berlin |
| 10:15 | The magic of, and lessons learned from, biofilm research | A Moter, Berlin |
| 10:30 | Aortic valve insufficiency on left ventricular assist device: Transcatheter approach – Transcatheter aortic valve implantation/amplatzer or just surgery? | A Cheung, Vancouver |
| 10:45 | Recurrent gastrointestinal bleeding: Treatment by medication, changing pump settings or pump exchange | U Jorde, New York |
| 11:00 | Pump thrombosis: A device or protocol related problem? | C Patel, North Carolina |
| 11:15 | State of the art in anticoagulation | J Long, Oklahoma City |
| 11:30 | State of the art in postoperative medical management | C Mahr, Seattle |
| 11:45 | Panel Discussion | |
| 12:00 | Wise Man: From the past to the future – Honorary lecture | E Braunwald, Massachusetts |
| 12:30 | The First EUMS Rising Stars Quiz | |
| 13:30 | Lunch | |
| Part III: Nothing Else Matters – The role of and need for ventricular assist device coordinators Chairs: C Mahr, Seattle; S Tsui, Cambridge |
||
| 14:30 | The view from Seattle, Berlin, Bad Oeynhausen, Paris and Louisville
J Beckman, Seattle Panel Discussion |
|
| 16:00 | Break | |
| Part IV: Long Way Home – Postoperative rehabilitation Chairs: U Jorde, New York; M Morshuis, Bad Oeynhausen |
||
| 16:30 | Pro – rehabilitation after ventricular assist device | E Langheim, Berlin |
| 16:45 | Contra – No need for an expensive hotel | J Fang, Salt Lake City |
| 17:00 | You have a message: Telemonitoring (INR, PA pressure, pump data), outsourcing? | J Long, Oklahoma City |
| 17:15 | Panel Discussion | |
| 18:00 | Close |
SATURDAY 5 NOVEMBER
| Part I: Kinderszenen – Old problems and new perspectives Chairs: A Amodeo, Rome; O Miera, Berlin |
||
| 08:00 | Ventricular assist device in small children | O Miera, Berlin |
| 08:15 | Thromboembolic events in children on ventricular assist device: Analysis of EUROMACS Registry | M Hübler, Zürich |
| 08:30 | Ventricular assist device in congenital heart disease | A Amodeo, Rome |
| 08:45 | Biventricular assist device in congenital heart disease | S Ovroutski, Berlin |
| 09:00 | Panel discussion | |
| Part II: That is the Way – Unusual cases and creative solutions Chairs: T Krabatsch, Berlin; I Netuka, Prague |
||
| 09:15 | A Cheung, Vancouver A Fiane, Oslo T Krabatsch, Berlin P Leprince, Paris M Morshuis, Bad Oeynhausen S Tsui, Cambridge |
|
| 10:15 | Break | |
| 10:45 | Part III: The Razor’s Edge – Update of current and prospective devices |
|
| Part IV: Street of Dreams – Innovations in the ventricular assist device field Chairs: P Leprince, Paris; M Slaughter, Louisville |
||
| 12:00 | Platelets, Thrombosis and Artificial Surfaces | F Ataullakhanov, Moscow |
| The ultimate physiologic control | A Petrou, Zürich | |
| Blood pumps without blood damage: How to achieve a dream? | U Kertzscher, Berlin | |
| The implanted cardiohemodynamics monitor | I Sergeev, Moscow | |
| Improving biocompatibility of ventricular assist device | C Mahr, Seattle | |
| Biomimetic membrane: What it takes to create a biocompatible deformable surface | E Mazza, Zürich | |
| 13:30 | Panel discussion | |
| 14:00 | Close |
COURSE INFORMATION
Date/Duration
3-5 November 2016 (3 day course)
Location
Maritim proArte Hotel Berlin
Friedrichstraße 151,
10117 Berlin
Germany
Chairmen
J Gummert, Bad Oeynhausen, P Leprince, Paris and V Falk, Berlin
Course Fee
Members: €550 inclusive of VAT
Non-Members: €650 inclusive of VAT
Course fee includes lunches, refreshments and welcome reception on Thursday 3 November
Course Format
3 day interactive lectures, live-in-a-box cases, keynote presentations and an Honoured Guest lecture by E Braunwald, Boston
Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and VAD coordinators, medical industry (cardiac device including ECMO development and production). Pediatric cardiologists and congenital heart disease surgeons
Learning Objectives
- Organising of heart failure network
- Use of ECLS systems in emergency situations and in the ICU
- Learning of recommendations for ECLS and VAD use from major societies and from recently published guidelines
- New surgical techniques for VAD implantation, as well as unusual solutions of complex surgical problems in VAD patients
- How to avoid long-term complications during VAD treatment
- Learn about the role and need for VAD coordinators
- The role of postoperative rehabilitation
- Latest developments and perspectives in the VAD field
Faculty
-
Eugene Braunwald
